Seagen Inc (SGEN)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Clay B. Siegall
Employees:
1,302
21823 30TH DRIVE SE, SUITE, BOTHELL, WA, 98021
4255274000

Seattle Genetics, Inc. engages in the development and commercialization of monoclonal antibody-based therapies for cancer. Its product ADCETRIS or brentuximab vedotin has been approved by both U.S. Food and Drug Association and Health Canada in U.S. and Canada respectively. ADCETRIS is an antibody-drug conjugate comprising an anti-CD30 monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, monomethyl auristatin E. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.

Data derived from most recent annual or quarterly report
Market Cap 28.791 Billion Shares Outstanding181.935 Million Avg 30-day Volume 951.281 Thousand
P/E Ratio38.144 Dividend Yield0.0 EPS-1.61
Price to Revenue0.0 Debt to Equity0.0 EBITDA670.412 Million
Price to Book Value7.3584 Operating Margin0.0 Enterprise Value22.669 Billion
Current Ratio7.966 EPS Growth2.978 Quick Ratio7.359
1 Yr BETA 0.6161 52-week High/Low 202.6 / 133.2 Profit Margin0.0
Operating Cash Flow Growth555.8327 Altman Z-Score30.134 Free Cash Flow to Firm 659.343 Million
View SEC Filings from SGEN instead.

View recent insider trading info

Funds Holding SGEN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SGEN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

114.7 Thousand total shares from 11 transactions

Exercise Derivative Conversion (M)

120.6 Thousand total shares from 7 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HIMES VAUGHN B CHIEF TECHNICAL OFFICER

  • Officer
203,316 2021-11-11 10

LIU JEAN I GC/EVP, LEG AFFAIRS

  • Officer
70,708 2021-11-04 9

SIMPSON TODD E CHIEF FINANCIAL OFFICER

  • Officer
255,450 2021-11-03 6

SIEGALL CLAY B PRESIDENT & CEO

  • Officer
  • Director
669,172 2021-09-23 14

DANSEY ROGER D CHIEF MEDICAL OFFICER

  • Officer
88,921 2021-09-23 6

ROMP CHARLES R EVP, COMMERCIAL

  • Officer
51,296 2021-09-23 5

BAKER BROS. ADVISORS LP

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
  • 10% Owner
94,871,537 2021-05-14 1

LOVE TED W

  • Director
6,663 2021-05-14 1

GRYSKA DAVID W

  • Director
49,712 2021-05-14 1

LIPPMAN MARC E

  • Director
57,202 2021-05-14 1

WELCH DANIEL G

  • Director
45,393 2021-05-14 2

SIMONIAN NANCY A

  • Director
30,962 2021-05-14 1

ORWIN JOHN A

  • Director
30,962 2021-05-14 1

SETH ALPNA

  • Director
14,912 2021-05-14 1

AKKARAJU SRINIVAS

  • Director
41,503 2020-05-15 0

TAYLOR ROBIN G CHIEF COMMERCIAL OFFICER

  • Officer
33,025 2019-12-19 0

CLINE DARREN S EVP, COMMERCIAL

  • Officer
72,556 2018-11-29 0

DRACHMAN JONATHAN G SEE REMARKS

  • Officer
0 2018-03-20 0

DOBMEIER ERIC CHIEF OPERATING OFFICER

  • Officer
119,860 2017-12-04 0

MCLAUGHLIN JOHN PETER

  • Director
39,400 2016-05-20 0

FBB3 LLC

  • Director
  • 10% Owner
12,678 2014-12-09 0

BAKER FELIX

BAKER JULIAN

BAKER BROS. ADVISORS (GP) LLC

BAKER BROS. ADVISORS LP

667, L.P.

BAKER BROTHERS LIFE SCIENCES LP

14159, L.P.

  • Director
  • 10% Owner
25,102,846 2014-12-08 0

BOERNER CHRISTOPHER S. EXECUTIVE VICE PRESIDENT, COMM

  • Officer
72,358 2014-08-24 0

BERGER FRANKLIN M

  • Director
204,720 2014-02-21 0

BAKER BROS. ADVISORS (GP) LLC

  • Director
  • 10% Owner
0 2013-07-01 0

BAKER FELIX

667, L.P.

BAKER BROTHERS LIFE SCIENCES LP

14159, L.P.

BAKER JULIAN

BAKER BROS ADVISORS LLC

  • Director
  • 10% Owner
19,487,448 2013-05-17 0

BAKER BROTHERS LIFE SCIENCES LP

  • Director
15,131,223 2013-05-17 0

14159, L.P.

  • Director
323,148 2013-05-17 0

667, L.P.

  • Director
3,868,576 2013-05-17 0

REYNOLDS THOMAS C CHIEF MEDICAL OFFICER

  • Officer
57,601 2013-01-25 0

FBB2 LLC

  • Director
  • 10% Owner
18,243 2012-06-15 0

ROSENBERG MORRIS EVP, PROCESS SCIENCES

  • Officer
17,643 2012-06-12 0

BAKER FELIX

  • Director
  • 10% Owner
0 2012-05-18 0

BAKER BROS ADVISORS LLC

  • Director
  • 10% Owner
0 2012-04-12 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
4,966,001 2011-12-30 0

BAKER BROS. CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
539,130 2011-12-30 0

BAKER / TISCH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
450,461 2011-12-30 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
15,131,223 2011-12-30 0

14159 CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
323,148 2011-09-06 0

SEELEY BRUCE J. EVP, COMMERICAL

  • Officer
18,861 2011-08-19 0

HOTH DANIEL FLOYD JR

  • Director
0 2010-05-21 0

JP MORGAN PARTNERS BHCA LP

JPMP MASTER FUND MANAGER L P

JPMP CAPITAL CORP

JP MORGAN PARTNERS GLOBAL INVESTORS LP

J P MORGAN PARTNERS GLOBAL INVESTORS A LP

J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP

J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP

JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP

JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L P

JPMP GLOBAL INVESTORS L P

  • 10% Owner
No longer subject to file 2008-07-28 0

H&Q HOLDINGS, INC.

H&Q EMPLOYEE VENTURE FUND 2000, L.P.

  • 10% Owner
No longer subject to file 2008-07-28 0

JP MORGAN PARTNERS BHCA LP

  • 10% Owner
No longer subject to file 2008-05-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HIMES VAUGHN B - Officer CHIEF TECHNICAL OFFICER

2021-11-12 18:51:07 -0500 2021-11-11 S 617 $179.84 d 59,845 direct yes -0.1478 -3.591 0.8375 4 -3.591 6

HIMES VAUGHN B - Officer CHIEF TECHNICAL OFFICER

2021-11-12 18:51:07 -0500 2021-11-11 M 6,000 $26.10 a 65,845 direct -0.1478 -3.591 0.8375 4 -3.591 6

HIMES VAUGHN B - Officer CHIEF TECHNICAL OFFICER

2021-11-12 18:51:07 -0500 2021-11-11 S 3,366 $178.82 d 60,462 direct yes -0.1478 -3.591 0.8375 4 -3.591 6

HIMES VAUGHN B - Officer CHIEF TECHNICAL OFFICER

2021-11-12 18:51:07 -0500 2021-11-11 M 6,000 d 22,866 direct

HIMES VAUGHN B - Officer CHIEF TECHNICAL OFFICER

2021-11-12 18:51:07 -0500 2021-11-11 S 2,017 $177.94 d 63,828 direct yes -0.1478 -3.591 0.8375 4 -3.591 6

SIMPSON TODD E - Officer CHIEF FINANCIAL OFFICER

2021-11-05 17:21:38 -0400 2021-11-04 M 2,156 $46.37 a 128,803 direct -2.3639 -4.0345 0.0 1 -6.8187 4

LIU JEAN I - Officer GC/EVP, LEG AFFAIRS

2021-11-05 17:21:44 -0400 2021-11-04 M 1,617 d 0 direct

LIU JEAN I - Officer GC/EVP, LEG AFFAIRS

2021-11-05 17:21:44 -0400 2021-11-04 M 1,617 $46.37 a 70,708 direct -2.3639 -4.0345 0.0 1 -6.8187 4

SIMPSON TODD E - Officer CHIEF FINANCIAL OFFICER

2021-11-05 17:21:38 -0400 2021-11-04 M 2,156 d 0 direct

SIMPSON TODD E - Officer CHIEF FINANCIAL OFFICER

2021-11-05 17:21:38 -0400 2021-11-03 M 40,232 d 0 direct

SIMPSON TODD E - Officer CHIEF FINANCIAL OFFICER

2021-11-05 17:21:38 -0400 2021-11-03 S 40,232 $185.00 d 126,647 direct yes -2.3639 -4.0345 0.0 1 -6.8187 4

SIMPSON TODD E - Officer CHIEF FINANCIAL OFFICER

2021-11-05 17:21:38 -0400 2021-11-03 M 40,232 $44.09 a 166,879 direct -2.3639 -4.0345 0.0 1 -6.8187 4

LIU JEAN I - Officer GC/EVP, LEG AFAIRS

2021-11-03 21:18:09 -0400 2021-11-01 S 6,222 $179.14 d 69,091 direct yes 0.904 -6.2226 0.904 2 -6.2226 6

LIU JEAN I - Officer GC/EVP, LEG AFAIRS

2021-11-03 21:18:09 -0400 2021-11-01 S 753 $175.08 d 98,546 direct yes 0.904 -6.2226 0.904 2 -6.2226 6

LIU JEAN I - Officer GC/EVP, LEG AFAIRS

2021-11-03 21:18:09 -0400 2021-11-01 M 34,876 $35.95 a 103,967 direct 0.904 -6.2226 0.904 2 -6.2226 6

LIU JEAN I - Officer GC/EVP, LEG AFAIRS

2021-11-03 21:18:09 -0400 2021-11-01 S 14,457 $178.07 d 75,313 direct yes 0.904 -6.2226 0.904 2 -6.2226 6

LIU JEAN I - Officer GC/EVP, LEG AFAIRS

2021-11-03 21:18:09 -0400 2021-11-01 S 2,588 $174.20 d 99,299 direct yes 0.904 -6.2226 0.904 2 -6.2226 6

HIMES VAUGHN B - Officer CHIEF TECHNICAL OFFICER

2021-11-03 19:20:00 -0400 2021-11-01 M 2,156 d 0 direct

LIU JEAN I - Officer GC/EVP, LEG AFAIRS

2021-11-03 21:18:09 -0400 2021-11-01 M 34,876 d 0 direct

LIU JEAN I - Officer GC/EVP, LEG AFAIRS

2021-11-03 21:18:09 -0400 2021-11-01 S 8,776 $177.29 d 89,770 direct yes 0.904 -6.2226 0.904 2 -6.2226 6

LIU JEAN I - Officer GC/EVP, LEG AFAIRS

2021-11-03 21:18:09 -0400 2021-11-01 S 2,080 $173.00 d 101,887 direct yes 0.904 -6.2226 0.904 2 -6.2226 6

HIMES VAUGHN B - Officer CHIEF TECHNICAL OFFICER

2021-11-03 19:20:00 -0400 2021-11-01 M 2,156 $46.37 a 59,845 direct 0.904 -6.2226 0.904 2 -6.2226 6

SIMPSON TODD E - Officer CHIEF FINANCIAL OFFICER

2021-11-02 18:46:08 -0400 2021-10-29 M 33,564 $41.04 a 160,211 direct 1.3068 -3.326 2.2227 3 -3.326 6

SIMPSON TODD E - Officer CHIEF FINANCIAL OFFICER

2021-11-02 18:46:08 -0400 2021-10-29 M 33,564 d 0 direct

SIMPSON TODD E - Officer CHIEF FINANCIAL OFFICER

2021-11-02 18:46:08 -0400 2021-10-29 S 33,564 $180.00 d 126,647 direct yes 1.3068 -3.326 2.2227 3 -3.326 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SEAGEN INC SGEN 2021-12-02 21:15:03 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 20:45:04 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 20:15:02 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 19:45:03 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 19:15:05 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 18:45:03 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 18:15:03 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 17:45:03 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 17:15:03 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 16:45:03 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 16:15:03 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 15:45:03 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 15:15:03 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 14:45:03 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 14:15:03 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 13:45:07 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 13:15:03 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-02 12:45:03 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-01 22:15:08 UTC -0.18 0.25 3200000
SEAGEN INC SGEN 2021-12-01 21:45:03 UTC -0.18 0.25 3200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AGF Investments Trust- AGFIQ U.S. Market Neutral Value Fund SGEN -22.0 shares, $-4305.18 2020-09-30 N-PORT
FundVantage Trust- Gotham Master Neutral Fund SGEN -21.0 shares, $-4109.49 2020-09-30 N-PORT
GMO TRUST- GMO Implementation Fund SGEN -6300.0 shares, $-1055880.0 2021-08-31 N-PORT
GMO TRUST- GMO Benchmark-Free Fund SGEN -2700.0 shares, $-452520.0 2021-08-31 N-PORT
GMO TRUST- GMO Strategic Opportunities Allocation Fund SGEN -400.0 shares, $-67040.0 2021-08-31 N-PORT
GMO TRUST- GMO Alternative Allocation Fund SGEN -300.0 shares, $-50280.0 2021-08-31 N-PORT
Leuthold Funds Inc- Leuthold Core Investment Fund SGEN -5303.0 shares, $-900449.4 2021-09-30 N-PORT
Leuthold Funds Inc- Leuthold Global Fund SGEN -18.0 shares, $-3056.4 2021-09-30 N-PORT
Leuthold Funds Inc- Grizzly Short Fund SGEN -4474.0 shares, $-759685.2 2021-09-30 N-PORT
AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF SGEN -1843.0 shares, $-312941.4 2021-09-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund SGEN -3800.0 shares, $-645240.0 2021-09-30 N-PORT

Elevate your investments